Industry Healthcare Founded 2015 | Website PureTech website | |
 | ||
Stock price PRTC (LON) 114.14 GBX -3.86 (-3.27%)30 Mar, 11:30 AM GMT+1 - Disclaimer Headquarters Boston, Massachusetts, United States Founders Daphne Zohar, Robert S. Langer, Yishai Zohar, John L Zabriskie Subsidiaries Follica, Enlight Biosciences, The Sync Project Executives Daphne Zohar, Joi Ito, Robert S Langer, Marjorie Scardino, Chris Viehbacher Profiles | ||
PureTech is a cross-disciplinary biotech company located in Boston, Massachusetts. The company has a pipeline of products in CNS, GI and immune indications, in emerging areas like the microbiome and digital medicine. PureTech identifies health care problems and works with employees, therapeutic area experts, and external partners to develop potential solutions.
Contents
Company overview
PureTech was founded by Daphne Zohar, John Zabriskie, and Robert Langer. Mark Ratner described PureTech in Nature Biotechnology as a firm that searches for "opportunity in forming companies around early-stage assets". Inc. Magazine described it as "an 'institutional founder,' which means it conceptualizes, incubates and founds companies".
Senior Partners at the firm include John LaMattina, former president of Pfizer Global Research and Development, MIT’s Robert Horvitz, Harvard’s Raju Kucherlapati, Joi Ito, director of the MIT Media Lab, former Sanofi CEO Christopher Viehbacher, and co-founder Bennett Shapiro, former executive vice president of worldwide licensing and external research at Merck. David R. Elmaleh is another advisor and cofounder.
Recent news
In May 2015 PureTech announced an IPO on the London Stock Exchange with the aim of raising $160 million to fund product development.
Pipeline
PureTech currently has 20 clinical studies across its pipeline, and has three pivotal stage and five post-human proof of concept products they include: